Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Margins of Excision × Drug Combinations × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 1 Sarcoma 1 Rectal Neoplasms 1 Plasmacytoma 1 Neoplasms 1 Neoplasm Metastasis 1 Margins of Excision 1 Homologous Recombination Deficient Solid Tumors 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Drug-Related Side Effects and Adverse Reactions 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Acrocephalosyndactylia 1

Interventions

Dermoscopy 2 varlilumab 1 Ultrasonography 1 Tumor Burden 1 Simvastatin 1 Radiosurgery 1 Observation 1 Neoadjuvant Therapy 1 Narrow Band Imaging 1 Microscopy, Confocal 1 Mastectomy, Segmental 1 Interferon alpha-2 1 Indocyanine Green 1 IFL protocol 1 Gastrectomy 1 Folfox protocol 1 Everolimus 1 Endoscopic Mucosal Resection 1 Drug Delivery Systems 1 Drug Combinations 1 Chemoradiotherapy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04389086 2022-09-06

PelvEx II

Catharina Ziekenhuis Eindhoven

Phase 3 Recruiting

Gastrointestinal

Margins of Excision, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡